STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER
- Country
- Netherlands
- Type
- Beneficiary
- Website
- www.bprc.nl
- Grants received
- 26
Funding record
- 26 grants on record
- €23,299,954.23 awarded in total
- 2009–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
6 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- Department of Health
- ISTITUTO SUPERIORE DI SANITA
- ACADEMISCH ZIEKENHUIS LEIDEN
- LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
- STATENS SERUM INSTITUT
- INSTITUT PASTEUR
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Calls from this organisation
No published calls from this organisation.
Grants received
- Parasite-host interactions regulating dormancy and reactivation of malaria parasites
- CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies
- Detailed Cortical Mechanisms of Top-Down Visual Processing
- Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity
- Integrated Services for Infectious Disease Outbreak Research
- DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE
- European Vaccine Research and Development Infrastructure
- Host switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training Network
- Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine
- Vaccine lot to Vaccine lot comparison by consistency testing.
- European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
- Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection
- TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
- Use of PRIMate MOdels to support translational MEDicine and advance disease modifying therapies for unmet medical needs
- Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.